Jazz Hits High Note With Updated Zanidatamab Data In Biliary Tract Cancer At ASCO

The company said it is in talks with the US FDA for an accelerated approval filing of the HER2-directed bispecific antibody, which showed better ORR and PFS than the standard of care.